BSX

Boston Scientific
D

BSX

Arincen84/100B

Boston Scientific cash on hand 1991–2026

Boston Scientific had 609.00M USD in cash and short-term investments on 30 September 2026, down 52.2% on a year before. At the end of fiscal year 2025 it had 2.05B USD.

Last updated 7 Nov 2026 · Next report 3 Feb 2027

Cash on hand

Growth

Fiscal yearPeriod endingCash on handGrowthTotal debtNet cash
Latest quarter30 Sept 2026609.00M-52.24%11.95B-11.34B
FY202531 Dec 20252.05B+393.96%11.85B-9.80B
FY202431 Dec 2024414.00M-52.14%11.15B-10.73B
FY202331 Dec 2023865.00M-6.79%9.49B-8.63B
FY202231 Dec 2022928.00M-51.79%9.28B-8.35B
FY202131 Dec 20211.93B+11.01%9.45B-7.53B
FY202031 Dec 20201.73B+699.08%9.54B-7.81B
FY201931 Dec 2019217.00M+48.63%10.28B-10.06B
FY201831 Dec 2018146.00M-22.34%7.03B-6.88B
FY201731 Dec 2017188.00M-4.08%5.58B-5.39B
FY201631 Dec 2016196.00M-38.56%5.48B-5.29B
FY201531 Dec 2015319.00M-45.66%5.68B-5.36B
FY201431 Dec 2014587.00M+170.51%4.26B-3.68B
FY201331 Dec 2013217.00M+4.83%4.24B-4.02B
FY201231 Dec 2012207.00M-22.47%4.26B-4.05B
FY201131 Dec 2011267.00M+25.35%4.26B-3.99B
FY201031 Dec 2010213.00M-75.35%5.44B-5.23B
FY200931 Dec 2009864.00M-47.35%5.92B-5.05B
FY200831 Dec 20081.64B+13.02%6.75B-5.10B
FY200731 Dec 20071.45B-12.95%8.19B-6.74B
FY200631 Dec 20061.67B+96.70%8.90B-7.23B
FY200531 Dec 2005848.00M-48.29%2.02B-1.17B
FY200431 Dec 20041.64B+144.41%2.37B-727.00M
FY200331 Dec 2003671.00M+142.24%1.73B-1.05B
FY200231 Dec 2002277.00M+49.73%935.00M-658.00M
FY200131 Dec 2001185.00M+208.33%1.20B-1.02B
FY200031 Dec 200060.00M-23.08%834.00M-774.00M
FY199931 Dec 199978.00M+10.95%1.28B-1.20B
FY199831 Dec 199870.30M+21.21%2.39B-2.32B
FY199731 Dec 199758.00M-0.85%493.50M-435.50M
FY199631 Dec 199658.50M-49.13%287.80M-229.30M
FY199531 Dec 1995115.00M+27.64%71.00M44.00M
FY199431 Dec 199490.10M+48.19%43.10M47.00M
FY199331 Dec 199360.80M-36.27%35.50M25.30M
FY199231 Dec 199295.40M+1,516.95%26.10M69.30M
FY199131 Dec 19915.90M—25.20M-19.30M

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Total debt,Free cash flow,Stock buybacks,Balance sheet

Common questions about Boston Scientific's cash

Source: Financial Modeling Prep